According to the official website of the US Senate, on September 19, the “Biosafety Law” targeting some Chinese biological companies was not included in the US “FY2025 National Defense Authorization Act”. The National Defense Authorization Act (NDAA) is a US federal law passed annually to define the budget, expenses, and policies of the US Department of Defense. This law is an important basis for deciding how to allocate defense funds, and also determines military project priorities and America's defense strategy. (Financial Services Association)